Hyderabad: A high level United States delegation, led by US International Development Finance Corporation (DFC) Chief Operating Officer David Marchick will visit Hyderabad shortly as part of its tour to advance DFC investments helping boost global health and expand COVID-19 vaccine production capacity.
DFC Vice President of Development Credit Jim Polan and other DFC senior staff will accompany the COO. The delegation, which will first visit South Africa, will arrive in India on October 24 and in Hyderabad, will visit the offices of vaccine manufacturer Biological E.
The delegation, according to an official press release, will participate in a signing ceremony to open a new facility with substantial capacity for vaccine manufacturing. This work is in support of the historic commitment set out by President Biden and his counterparts in the “Quad” – Australia, India, Japan, and the United States, the release said, adding that since day one of the Biden Administration, President Biden has stated that the only way to defeat COVID-19 is to end the pandemic both at home and abroad by vaccinating Americans at home and non-Americans abroad.
So far, the United States committed to donating 1.1 billion doses of vaccines and has already shipped nearly 200 million doses to developing countries – more doses than the rest of the world combined, it said.
DFC’s financial tools are driving growth in vaccine manufacturing capacity in multiple regions, with multiple technologies and within large and small countries. Already, DFC’s support is projected to facilitate capacity expansion to produce nearly two billion COVID-19 vaccine doses across the globe by the end of 2022, with more projects in the pipeline. The agency is also working on expanding access to critical therapeutics and introducing medical equipment designed for low-resource environments, it added.